Innophos Holdings, Inc. (IPHS)
(Delayed Data from NSDQ)
$33.81 USD
+1.67 (5.20%)
Updated May 3, 2019 04:00 PM ET
After-Market: $33.83 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$33.81 USD
+1.67 (5.20%)
Updated May 3, 2019 04:00 PM ET
After-Market: $33.83 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Innophos (IPHS) Earnings Lag Estimates in Q3, Revenues Beat
by Zacks Equity Research
Softer demand, discontinuation of the low-margin nutrition trading business and the indirect effects of tariffs affected Innophos (IPHS) in Q3.
Innophos (IPHS) Earnings Top Estimates in Q2, Revenues Lag
by Zacks Equity Research
Weaker demand, discontinuation of low-margin nutrition trading business and effects of tariffs hurt Innophos' (IPHS) Q2 sales.
Innophos Holdings (IPHS) Q2 Earnings Surpass Estimates
by Zacks Equity Research
Innophos (IPHS) delivered earnings and revenue surprises of 22.86% and -7.99%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Innophos Holdings (IPHS) Q2 Earnings Expected to Decline
by Zacks Equity Research
Innophos (IPHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Innophos Holdings (IPHS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Innophos (IPHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Innophos Holdings (IPHS) Q1 Earnings Expected to Decline
by Zacks Equity Research
Innophos (IPHS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Innophos (IPHS) Earnings Top Estimates in Q4, Sales Flat Y/Y
by Anindya Barman
Innophos (IPHS) gains from a stabilized base business and pricing actions in Q4. It envisions revenues in 2019 to be mostly in line with the 2018 level.
Innophos (IPHS) Earnings Miss Estimates in Q3, Sales Rise Y/Y
by Zacks Equity Research
Innophos (IPHS) expects year-over-year adjusted EPS growth of 3-7% in 2018.
What Could Dampen Chemical Industry Momentum?
by Zacks Equity Research
There are a few reasons to be mindful about the chemical industry in the near term.
Innophos (IPHS) Q4 Earnings Lag Estimates, Sales Up Y/Y
by Zacks Equity Research
Strength in the FHN segment drove Innophos Holdings' (IPHS) revenues in Q4, but the company's earnings missed expectations.
Innophos Holdings (IPHS) Stock Up 15% in 3 Months: Here's Why
by Zacks Equity Research
Strong Q2 results, healthy outlook and upbeat prospects stemming from Novel Ingredients buyout have provided a boost to Innophos' (IPHS) shares.
Chemours' (CC) Solid Product Offerings Make it a Must Buy
by Zacks Equity Research
The Chemours Company (CC) is poised to gain from end-market demand for its products. Also, innovative products and expansionary efforts will prove advantageous.
PPG Industries' (PPG) Teslin Substrate Gets ISEGA Certificate
by Zacks Equity Research
PPG Industries' (PPG) Teslin Food-Grade substrate receives ISEGA certification, which can be safely used for numerous European packaging applications and food labeling.
Praxair Gains From Contract Wins, Solid Demand, Risks Remain
by Zacks Equity Research
Praxair (PX) will gain from diversified business structure, solid product demand and contract wins. High debt, stiff competition and global uncertainties remain issues.
Top Ranked Income Stocks to Buy for September 5th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, September 5th:
New Strong Buy Stocks for September 1st
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
5 Reasons to Add Innophos (IPHS) Stock to Your Portfolio
by Zacks Equity Research
Based on its compelling prospects, we believe Innophos (IPHS) has plenty of upside potential.
New Strong Buy Stocks for August 30th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
Innophos Declares Closure of Novel Ingredients Acquisition
by Zacks Equity Research
Innophos Holdings (IPHS) announced the closure of its acquisition deal with Novel Ingredients, creating a $0.5 billion Food, Health and Nutrition platform.
New Strong Buy Stocks for August 23rd
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
Here's Why Innophos Holdings is a Good Investment Choice
by Zacks Equity Research
Innophos Holdings, Inc. (IPHS) is poised to gain from its cost-savings initiatives and Novel Ingredients buyout. The acquisition will help in creating a Food, Health and Nutrition platform.
New Strong Buy Stocks for August 11th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Chemical Stocks Earnings Roster for May 1: CC, CBT & IPHS
by Zacks Equity Research
We peek at three chemical companies that are slated to report quarterly results on May 1.
New Strong Sell Stocks for April 18th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Zacks Industry Outlook Highlights: Kraton, Innophos Holdings, Trecora Resources and Rayonier Advanced Materials
by Zacks Equity Research
Zacks Industry Outlook Highlights: Kraton, Innophos Holdings, Trecora Resources and Rayonier Advanced Materials